Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;131(9):97009.
doi: 10.1289/EHP11811. Epub 2023 Sep 26.

Exposure to Perfluoroalkyl Substances and Associations with Pubertal Onset and Serum Reproductive Hormones in a Longitudinal Study of Young Girls in Greater Cincinnati and the San Francisco Bay Area

Affiliations

Exposure to Perfluoroalkyl Substances and Associations with Pubertal Onset and Serum Reproductive Hormones in a Longitudinal Study of Young Girls in Greater Cincinnati and the San Francisco Bay Area

Susan M Pinney et al. Environ Health Perspect. 2023 Sep.

Abstract

Background: Per- and polyfluoroalkyl substances (PFAS), endocrine disrupting chemicals with worldwide exposure, cause changes in mammary gland development in rodents. A few human studies report delay in pubertal events with increasing perfluorooctanoic acid (PFOA) exposure, but to our knowledge none have examined reproductive hormone levels at thelarche.

Methods: In a cohort of Greater Cincinnati (GC) and San Francisco Bay Area (SFBA) girls recruited at 6-8 years of age, clinical examinations were conducted annually or semiannually with sequential Tanner staging. PFAS concentrations were measured in the first serum sample of 704 girls. In 304 GC girls, estradiol (E2), estrone (E1), testosterone (T), and dihydroepiandrosterone sulfate (DHEAS) were measured in serum at four time points around puberty. Relationships between PFAS and age at thelarche, pubarche, and menarche were analyzed using survival and structural equation models. The association between PFAS and reproductive hormones was assessed using linear regression models.

Results: Median PFOA serum concentrations in GC (N=353, 7.3 ng/mL) and the SFBA (N=351, 5.8 ng/mL) were higher than in the U.S.

Population: In multivariable Cox proportional hazard models [adjusted for race, body mass index (BMI)], increasing serum log-transformed PFOA was associated with a delay in pubarche [hazard ratio (HR)=0.83; 95% CI: 0.70, 0.99] and menarche (HR=0.04; 95% CI: 0.01, 0.25). Structural equation models indicated a triangular relationship between PFOA, BMI percentile, and the age at the pubertal milestone. Increased PFOA had a statistically significant direct effect of delay on all three milestones, as did BMI. Perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDeA), and 2-(N-methyl-perfluorooctane sulfonamido) acetic acid (Me-PFOSA-AcOH) also were associated with later thelarche, and Me-PFOSA-AcOH also with later pubarche. PFOA was inversely associated with DHEAS (p<0.01), E1 (p=0.04), and T (p=0.03) concentrations at 6 months prior to puberty.

Conclusions: PFAS may delay pubertal onset through the intervening effects on BMI and reproductive hormones. The decreases in DHEAS and E1 associated with PFOA represent biological biomarkers of effect consistent with the delay in onset of puberty. https://doi.org/10.1289/EHP11811.

PubMed Disclaimer

Figures

Figures 1A to 1C are line graphs titled Age of Thelarche, Age of Pubarche, and Age of Menarche, plotting Survival probability, ranging from 0.0 to 1.0 in increments of 0.2 (y-axis) across Age of Thelarche (months), ranging from 0 to 150 in increments of 50; Age of Pubarche (months), ranging from 0 to 150 in increments of 50; and Age of Menarche (months), ranging from 0 to 200 in increments of 50 (x-axis), for Perfluorooctanoic acid and Body mass index percentage levels, including High perfluorooctanoic acid, High body mass index; High perfluorooctanoic acid, Low body mass index; Low perfluorooctanoic acid, High body mass index; and Low perfluorooctanoic acid, Low body mass index.
Figure 1.
Kaplan–Meier curve estimates of cumulative probability of achieving a pubertal milestone, stratified by PFOA serum concentration and BMI%. (Greater Cincinnati and San Francisco Bay Area girls, n=704, 2004–2014.) Pubertal milestones: (A) age of thelarche, (B) age of pubarche, and (C) age of menarche. BMI strata for milestone A: BMI% strata, low <65.7%, high 65.7%; PFOA strata, low 6.4 ng/mL, high 6.4 ng/mL. BMI strata for milestone B: BMI% strata, low <67.6%, high 67.6%; PFOA strata, low <6.4 ng/mL, high 6.4 ng/mL. BMI strata for milestone C: BMI% strata, low <67.3%, high 67.3%; PFOA strata, low <6.4 ng/mL, high 6.4 ng/mL. Note: BMI, body mass index; BMI%, BMI percentile; CDC, Centers for Disease Control and Prevention; PFOA, perfluorooctanoic acid.
Figure 2A is a flowchart titled Age of Thelarche with two steps. Step 1: Asian (lowercase beta equals 1.28, lowercase p equals 0.01), Hispanic (lowercase beta equals 0.74, lowercase p less than 0.01), Black (lowercase beta equals 0.57, lowercase p less than 0.01), Perfluorooctanoic acid (logged) (lowercase beta equals 0.38, lowercase p less than 0.04) lead to body mass index percentage. Step 2: Perfluorooctanoic acid (logged) (hazard ratio equals 0.73, 95 percent confidence interval (0.62, 0.87), lowercase p less than 0.01), Body mass index percentage (hazard ratio equals 1.97, 95 percent confidence interval (1.63, 2.38), lowercase p less than 0.01), and Site (hazard ratio equals 0.49, 95 percent confidence interval (0.41, 0.59), lowercase p less than 0.01) lead to Age of Thelarche. Figure 2B is a flowchart titled Age of Pubarche with two steps. Step 1: Asian (lowercase beta equals 1.44, lowercase p equals 0.01), Hispanic (lowercase beta equals 0.74, lowercase p less than 0.01), Black (lowercase beta equals 0.73, lowercase p less than 0.01), Perfluorooctanoic acid (logged) (lowercase beta equals negative 0.50, lowercase p equals 0.01) lead to body mass index percentage. Step 2: Perfluorooctanoic acid (logged) (hazard ratio equals 0.70, 95 percent confidence interval (0.60, 0.81), lowercase p less than 0.01), Body mass index percentage (hazard ratio equals 1.65, 95 percent confidence interval (1.40, 1.94), lowercase p less than 0.01), and Site (hazard ratio equals 0.85, 95 percent confidence interval (0.72, 1.00), lowercase p equals 0.06) lead to Age of Pubarche. Figure 2C is a flowchart titled Age of Menarche with two steps. Step 1: Asian (lowercase beta equals 1.10, lowercase p equals 0.02), Hispanic (lowercase beta equals 0.91, lowercase p less than 0.01), Black (lowercase beta equals 0.95, lowercase p less than 0.01), Perfluorooctanoic acid (logged) (lowercase beta equals 0.33, lowercase p equals 0.08) lead to body mass index percentage. Step 2: Perfluorooctanoic acid (logged) (hazard ratio equals 0.73, 95 percent confidence interval (0.63, 0.87), lowercase p less than 0.01), Body mass index percentage (hazard ratio equals 2.14, 95 percent confidence interval (1.76, 2.60), lowercase p less than 0.01), and Site (hazard ratio equals 0.92, 95 percent confidence interval (0.77, 1.11), lowercase p equals 0.41) lead to Age of Menarche.
Figure 2.
SEM of effects of PFOA and other factors on age at pubertal milestone in months (Greater Cincinnati and San Francisco Bay Area girls, n=700, 2004–2014. Pubertal milestones: (A) age of thelarche, (B) age of pubarche, and (C) age of menarche. SEM analysis using Mplus: survival- and regression-mediated analysis; BMI=1<85th percentile (reference), 2=85th percentile; Asian: 0=White, Hispanic, Black (reference), 1=Asian; Hispanic: 0=White, Asian, Black (reference), 1=Hispanic; Black: 0=White, Asian, Hispanic (reference), 1=Black; Site: 0=GC (reference), 1=SFBA; PFOA=PFOA serum concentration (logged). Note: BMI, body mass index; CI, confidence interval; GC, Greater Cincinnati; HR, hazard ratio; PFOA, perfluorooctanoic acid (logged); SEM, structural equation model; SFBA, San Francisco Bay Area.
Figure 3 is an estrogen biosynthesis pathway with fourteen steps. Step 1: Cholesterol leads to Pregnenolone. Step 2: Pregnenolone leads to Progesterone and 17-hydroxypregnenolone. Step 3: Progesterone leads to 17-hydroxyprogesterone. Step 4: 17-hydroxypregnenolone leads to Dehydroepiandrosterone. Step 5: 17-hydroxyprogesterone and Dihydroandrostendione lead to Androstenedione. Step 6: Dehydroepiandrosterone leads to Androstenedione . Step 7: There is a bidirectional relationship between Dehydroepiandrosterone and Androstenediol. Step 8: There is a bidirectional relationship between Androstenedione and Testosterone. Step 9: Androstenedione leads to Estrone. Step 10: Androstenediol leads to Testosterone. Step 11: There is a bidirectional relationship between Testosterone and Estradiol. Step 12: There is a bidirectional relationship between Estrone and Estradiol. Step 13: Estradiol leads to 4-hydroxyestradiol. Step 14: 4-hydroxyestradiol leads to 4-methoxyestradiol.
Figure 3.
Estrogen biosynthesis pathway (circulating hormones and at tissue level). Note: DHEA, dehydroepiandrosterone; OH, hydroxy.

Comment in

References

    1. Bernstein L. 2002. Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7(1):3–15, PMID: , 10.1023/a:1015714305420. - DOI - PubMed
    1. Golub MS, Collman GW, Foster PMD, Kimmel CA, Rajpert-De Meyts E, Reiter EO, et al. . 2008. Public health implications of altered puberty timing. Pediatrics 121(suppl 3):S218–S230, PMID: , 10.1542/peds.2007-1813G. - DOI - PubMed
    1. Bodicoat DH, Schoemaker MJ, Jones ME, McFadden E, Griffin J, Ashworth A, et al. . 2014. Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study. Breast Cancer Res 16(1):R18, PMID: , 10.1186/bcr3613. - DOI - PMC - PubMed
    1. Biro FM, Deardorff J. 2013. Identifying opportunities for cancer prevention during preadolescence and adolescence: puberty as a window of susceptibility. J Adolesc Health 52(suppl 5):S15–S20, PMID: , 10.1016/j.jadohealth.2012.09.019. - DOI - PMC - PubMed
    1. Hiatt RA, Haslam SZ, Osuch J, Breast Cancer and the Environment Research Centers. 2009. The Breast Cancer and the Environment Research Centers: transdisciplinary research on the role of the environment in breast cancer etiology. Environ Health Perspect 117(12):1814–1822, PMID: , 10.1289/ehp.0800120. - DOI - PMC - PubMed

Publication types

LinkOut - more resources